Fingerprint
Dive into the research topics where Kimberly Brooke Koenig is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 22 Article
-
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study
Yam, C., Patel, M., Hill, H. A., Sun, R., Bassett, R. L., Kong, E., Damodaran, S., Koenig, K. B., Abouharb, S., Saleem, S., Bisen, A. K., Murthy, R. K., Ramirez, D. L., Rauch, G. M., Adrada, B. E., Candelaria, R. P., Wang, X., Mittendorf, E. A., Thompson, A. M. & White, J. B. & 19 others, , Oct 2024, In: Cancer Research Communications. 4, 10, p. 2823-2834 12 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
Short-Term Biomarker Modulation Study of Dasatini for Estrogen Receptor–Negative Breast Cancer Chemoprevention
Mustafayev, F. N. A., Liu, D. D., Gutierrez, A. M., Lewis, J. E., Ibrahim, N. K., Valero, V., Booser, D. J., Litton, J. K., Koenig, K., Yu, D., Sneige, N. & Arun, B. K., Oct 2023, In: European Journal of Breast Health. 19, 4, p. 267-273 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy
Abuhadra, N., Sun, R., Bassett, R. L., Huo, L., Chang, J. T., Teshome, M., Clayborn, A. R., White, J. B., Ravenberg, E. E., Adrada, B. E., Candelaria, R. P., Yang, W., Ding, Q., Symmans, W. F., Arun, B., Damodaran, S., Koenig, K. B., Layman, R. M., Lim, B. & Litton, J. K. & 9 others, , Jun 2023, In: Investigational New Drugs. 41, 3, p. 391-401 11 p.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Scopus citations -
Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors
Yao, S., Janku, F., Koenig, K., Tsimberidou, A. M., Piha-Paul, S. A., Shi, N., Stewart, J., Johnston, A., Bomalaski, J., Meric-Bernstam, F. & Fu, S., Jan 2022, In: Cancer medicine. 11, 2, p. 340-347 8 p.Research output: Contribution to journal › Article › peer-review
Open Access21 Link opens in a new tab Scopus citations -
A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer
Lim, B., Song, J., Ibrahim, N. K., Koenig, K. B., Chavez-MacGregor, M., Ensor, J. E., Gomez, J. S., Krishnamurthy, S., Caudle, A. S., Shaitelman, S. F., Whitman, G. J. & Valero, V., Feb 2021, In: Oncologist. 26, 2, p. e230-e240Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations